Olema Pharmaceuticals, Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Olema Pharmaceuticals, Inc.
- Company name
- Olema Pharmaceuticals, Inc.
- Organisation type
- Industry
- Registered legal name
- Olema Pharmaceuticals, Inc.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001750284
Related records
Trials (6)
- A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer
- A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients
- OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
- Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer